Marketing, media, wishful thinking, and conflicts of interest: inflating the value of new medical technology.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  The Permanente Journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Business

• Identifiers
  DOI 10.7812/TPP/08-087PMID 21373235PMCID PMC3034436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Newly approved does not always mean new and improved.

  2008cited by this paper
• Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.

  2008cited by this paper
• A randomized trial of arthroscopic surgery for osteoarthritis of the knee.

  2008cited by this paper
• [A randomized trial of arthroscopic surgery for osteoarthritis of the knee].

  2008cited by this paper
• Selective publication of antidepressant trials and its influence on apparent efficacy.

  2008cited by this paper
• Conflict of interest in orthopaedic research. An association between findings and funding in scientific presentations.

  2007cited by this paper
• Relationship between conflicts of interest and research results

  2007cited by this paper
• Variation in Reported Safety of Lumbar Interbody Fusion: Influence of Industrial Sponsorship and Other Study Characteristics

  2007cited by this paper
• Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.

  2006cited by this paper
• National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation.

  2005cited by this paper
• Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal inflammatory drugs: Nested case-control study

  2005cited by this paper
• Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.

  2005cited by this paper
• Economic implications of evidence-based prescribing for hypertension: can better care cost less?

  2004cited by this paper
• Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

  2003cited by this paper
• Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

  2003cited by this paper
• Pharmaceutical industry sponsorship and research outcome and quality: systematic review

  2003cited by this paper
• A controlled trial of arthroscopic surgery for osteoarthritis of the knee.

  2002cited by this paper
• A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors.

  2002cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• New National Emphysema Treatment Trial paradigm of Health Care Financing Administration-sponsored clinical research trials: advances and dilemmas.

  2002cited by this paper
• Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ

  2002cited by this paper
• How interested are Americans in new medical technologies? A multicountry comparison.

  2001cited by this paper
• The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer.

  2001cited by this paper
• Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis.

  1999cited by this paper
• Whose article is it anyway?

  1999cited by this paper
• The messenger under attack -- intimidation of researchers by special-interest groups.

  1997cited by this paper
• Thyroid storm.

  1997cited by this paper
• Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.

  1997cited by this paper
• Impact of covert duplicate publication on meta-analysis: a case study

  1997cited by this paper
• Influences on the Quality of Published Drug Studies

  1996cited by this paper
• Redundancy, disaggregation, and the integrity of medical research.

  1996cited by this paper
• A partisan assault on science--the threat to the CDC.

  1995cited by this paper
• Special report. The brief life of the National Center for Health Care Technology.

  1982cited by this paper

• Reflections on Terms, Goals and Organisation

  2017cites this paper
• Temporal Trends of Corporate Sponsorship in Medical Research

  2016cites this paper
• Sparing your spine.

  2015cites this paper
• PREVENTION & REHABILITATION: SELF-MANAGEMENT: PATIENT SECTION

  2015cites this paper